Moflomycin

TargetMol
Product Code: TAR-T24492
Supplier: TargetMol
CodeSizePrice
TAR-T24492-5mg5mg£1,733.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24492-50mg50mg£3,428.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24492-100mg100mg£4,729.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Moflomycin is an anthracycline derivative. It exhibits a higher antileukemic activity compared to other anthracyclines.
CAS:
107430-03-5
Formula:
C25H25IO10
Molecular Weight:
612.369
Purity:
0.98
SMILES:
C[C@@H]1O[C@@H](O[C@H]2C[C@](O)(CO)Cc3c(O)c4C(=O)c5ccccc5C(=O)c4c(O)c23)[C@H](I)[C@H](O)[C@H]1O

References

1. Andrivon W, Monneret C, Nafziger J, Florent JC, Guillosson JJ. A new anthracycline with potent anti-leukemic activity overcomes P-glycoprotein multidrug resistance. Leuk Res. 1998 Aug;22(8):719-25. PubMed PMID: 9680099. 2. Andrivon W, Callais F, Nafziger J, Monneret C, Guillosson JJ. A new anthracycline with potent antileukemic activity exhibits reduced mutagenicity. Mutat Res. 1995 Oct;344(3-4):135-40. PubMed PMID: 7491131. 3. Florent JC, Genot A, Monneret C. Synthesis and antitumor activity of new anthracyclines. J Antibiot (Tokyo). 1989 Dec;42(12):1823-30. Erratum in: J Antibiot (Tokyo) 1990 Mar;43(3):C-1. PubMed PMID: 2621164. 4. Nafziger J, Auclair C, Florent JC, Guillosson JJ, Monneret C. Pharmacological and physicochemical properties of a new anthracycline with potent antileukemic activity. Leuk Res. 1991;15(8):709-13. PubMed PMID: 1654481.